Stock Analysis · Healthcare Realty Trust Incorporated (HR)
Overview
Healthcare Realty Trust Incorporated is a real estate investment trust, or REIT, focused on medical outpatient buildings. In simple terms, it owns and manages properties where healthcare services are delivered outside hospitals, such as physician offices, specialty clinics, surgery-related facilities, and other buildings used by health systems and medical groups. The company’s portfolio is concentrated around major healthcare campuses and large metropolitan markets, which is important because these locations tend to be tied to established patient demand and referral networks.
The business model is straightforward: Healthcare Realty collects rent from tenants that use its buildings for patient care and related healthcare services. Because it is a REIT, property income, occupancy, leasing spreads, capital recycling, and debt costs matter more than product launches or manufacturing trends.
Based on its recent annual disclosures, revenue is overwhelmingly rental and property-related, with only a small portion coming from other real estate activities. The mix can be summarized as follows:
- Rental revenue: approximately 95% to 97% — base rent and recoveries from tenants leasing medical outpatient buildings.
- Other property income and fees: approximately 3% to 5% — items such as parking, lease-related reimbursements, and other ancillary real estate revenue.
The bigger strategic point is that Healthcare Realty is not a broad healthcare company. It is a specialized landlord serving the outpatient side of healthcare delivery, which gives it a narrower but easier-to-understand business model than many diversified real estate owners.
The financial flow over the last several years shows a company that became much larger after its major portfolio combination, but that scale did not translate into cleaner profitability. Revenue expanded materially through 2023, then moved lower in 2024 and 2025 as the company sold assets and worked through a portfolio reset. Interest expense remained heavy throughout, which helps explain why reported earnings stayed under pressure even as the underlying real estate platform remained sizable.
Key Figures
| Metric | Value | Sector ⓘ |
|---|---|---|
| Date | Oct 17, 2026 | |
| Context | ||
| Sector | Real Estate | |
| Industry | REIT - Healthcare Facilities | |
| Market Cap ⓘ | $5.91B | |
| Beta ⓘ | 0.84 | |
Value (Cheapness) | ||
| P/E Ratio ⓘ | N/A | 17.38 |
| P/B Ratio ⓘ | 1.43 | 0.85 |
| FCF Yield ⓘ | 2.28% | 7.38% |
| Dividend Yield ⓘ | 5.57% | 4.85% |
| EBIT / EV ⓘ | 1.26% | 3.78% |
| PEG ⓘ | 8.82 | |
Growth (Business expansion) | ||
| Revenue Growth ⓘ | -4.30% | 5.30% |
| RPS Growth (5Y CAGR) ⓘ | -2.58% | 6.02% |
| EPS Growth (5Y CAGR) ⓘ | N/A | -11.37% |
| BVPS Growth (5Y CAGR) ⓘ | -3.96% | 0.45% |
| Margin Growth (5Y Trend) ⓘ | N/A | -0.22% |
| FCF Growth (5Y CAGR) ⓘ | -0.96% | 5.40% |
| DPS Growth (5Y CAGR) ⓘ | -2.61% | 5.02% |
Quality (Business durability) | ||
| ROIC (Latest) ⓘ | 1.20% | 5.69% |
| ROE (Latest) ⓘ | -2.00% | 7.56% |
| ROA (Latest) ⓘ | -0.92% | 2.85% |
| ROIC (5Y Median) ⓘ | -0.37% | 4.22% |
| ROE (5Y Median) ⓘ | -3.91% | 6.03% |
| ROA (5Y Median) ⓘ | -2.10% | 2.44% |
| Net Debt / EBIT (Latest) ⓘ | 33.04 | 7.59 |
| Net Debt / EBIT (5Y Median) ⓘ | N/A | 8.40 |
| Net Debt / EBITDA (Latest) ⓘ | 6.25 | 5.27 |
| Net Debt / Assets ⓘ | 48.70% | 37.76% |
| EBITDA / Interest ⓘ | 3.88 | 4.10 |
| Operating Margin (Latest) ⓘ | 11.59% | 35.29% |
| Operating Margin (5Y Median) ⓘ | -1.00% | 37.31% |
| Debt to Equity (Latest) ⓘ | 104.40% | 88.87% |
| Profit Margin (Latest) ⓘ | -7.57% | 19.61% |
| Free Cash Flow (Latest) ⓘ | $134.84M | |
Momentum (Price trend) | ||
| 3Y Return ⓘ | +40.37% | +30.75% |
| 12M Return (excl. last month) ⓘ | +8.57% | +4.36% |
| 6M Return ⓘ | -0.19% | -2.52% |
| Price vs. 200-Day MA ⓘ | -6.08% | -2.34% |
Healthcare Realty is a mid-to-large healthcare REIT with a market value in the several-billion-dollar range and a stock that has shown somewhat lower volatility than the broader equity market. The mixed picture in the table is important. Momentum has improved relative to many peers, but value, growth, and especially quality metrics remain weak. Free cash flow yield and operating profitability trail sector medians, while leverage is still elevated. The dividend yield is above the sector median, but that higher yield comes alongside slower growth and a weaker earnings profile rather than clear financial strength.
Growth
Healthcare outpatient real estate sits in an area with long-term structural support. An aging population, steady demand for physician services, and the healthcare system’s shift toward lower-cost outpatient settings all support the need for medical office space over time. This is not usually a fast-growth business, but it can be a durable one when buildings are well located and linked to strong hospital systems.
Healthcare Realty’s strategy is built around that idea. The company has emphasized medical outpatient buildings in markets with large health systems, and in recent years it has been simplifying the portfolio by selling non-core properties, reducing joint venture complexity, and concentrating capital where management believes leasing demand and returns are stronger. That strategy is logical for long-term positioning because it favors focus over size for its own sake.
One caution is that growth has not yet shown up clearly in per-share terms. Revenue per share has drifted lower over the past five years, which means the benefits of portfolio scale, leasing activity, and asset reshaping have not yet translated into stronger revenue on a per-share basis. Compared with many real estate peers, this leaves the company in a weaker growth position today.
The dividend record also reflects that transition period. Dividend per share has been uneven and is lower than it was several years ago, even though the current yield remains noticeable. For a REIT, this matters because a stable or rising dividend often signals steady operating performance and confidence in recurring cash generation. In Healthcare Realty’s case, the payout still plays an important role in the investment profile, but the recent history points to a business still working through a reset rather than one already in a clean expansion phase.
A meaningful catalyst is the company’s continued effort to improve occupancy, lease more space in the same-store portfolio, and sell lower-quality assets to support the balance sheet. If these steps lead to better property-level margins and lower financing pressure, the business could look stronger even without rapid top-line growth. Another potential tailwind is the interest-rate backdrop: healthcare REITs generally benefit when financing conditions become less restrictive, because debt costs and property valuations are both sensitive to rates.
Recent company updates have continued to highlight portfolio recycling, leasing execution, and balance-sheet management rather than aggressive expansion. That is not the profile of a company chasing headline growth, but it can still create a significant opportunity if operations become more efficient and the remaining asset base proves stronger than the one being sold off.
Risks
This article is for informational purposes only and does not constitute financial advice. Some content is AI-generated. See Disclaimer